Skip to content

1998 revision to the British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals

News from the British HIV Association Fifth Annual Meeting

Atlantic study shows PI-sparing combos match indinavir after 48 weeks

Adefovir rejected for US license

40% of French combo patients have detectable viral load

Efavirenz side effects become long-term for over one in three

Virgin Islands conference summaries

UK joins new study on how to treat HIV in children: exclusive interview with Dr Gareth Tudor-Williams.

First human study of follow-on fusion inhibitor